Dr. Subbaya Subramanian is a cancer researcher who completed his postdoctoral fellowship at Stanford University. Dr. Subramanian is currently working as an Associate Professor in the Department of Surgery at the University of Minnesota. As a faculty at the University of Minnesota, he has established an internationally recognized cancer research program focused on deciphering the molecular mechanisms of colorectal cancer development and progression. His current research focuses on understanding the interactions between cancer and the host immune system and how cancer cells manipulate the anti-tumor immune response. His goal is to translate the knowledge gained into valid therapeutic targets and to develop novel clinical applications. Dr. Subramanian is an author of over 100 peer-reviewed publications and has written numerous book chapters and review articles. He is the Associate Editor-in-Chief of the journal Cancers and serves as the Section Editor-in-Chief of Vaccines. Dr. Subramanian also serves on the Editorial Board of several journals including Scientific Reports. He is a co-founder and Chief Scientific Officer of EV Therapeutics Inc., which develops exosome-based cancer therapies for advanced-stage cancers.

Dr. Shyamapada Mandal, Professor, Department of Zoology, University of Gour Banga, India, is interested re-PhD, PhD, and post-PhD research under the guidance of Professor Nishith Kumar Pal at Calcutta School of Tropical Medicine, India. He has published 115 articles with seven book chapters. He is life member of IAMM and IASR, India, and fellow member of SASS, India. Eight national academic and research awards have been conferred to him. He has guided 52 post graduate students; supervised three MPhil and three PhD students, and supervising 6 PhD students. Professor Mandal is among the world’s top 2% scientists as per the survey of the Stanford University, published in PLOS (Public Library of Science) Biology (October, 2020).

Prof Swapna Chaudhuri is an alumnus of University of Calcutta. Presently she is an Emeritus Medical Scientist at Chittaranjan National Cancer Institute,Calcutta, India.She had joined School of Tropical Medicine in 2008 as Professor. Her research area is the fields of Cancer Immunology and Immunotherapy, Respiratory and Infectious Immunology and Immunotherapy, Cryptoccocal Immunology and Immunotherapy and Haematopoitic Stem cell Immunology and Immunotherapy.Taught at both postgraduate and undergraduate levels. Published seventy five papers in high impact factor journals and also reviews, monograms, book chapters, commentaries. Has won many Academic laurels and Fellowships, affiliated to twelve Academic Societies, Editorial Committee member of many National and International journals, Reviewer of fifty six high impact factor journals, Principal Investigator of twenty one projects, Supervised 21 PhD, MD and DM students.

Xiao-Jing Wang, M.D., Ph.D., is a John S. Gates Endowed Chair of Cancer Stem Cell Biology and Director of head & neck cancer research program at UCD, Professor in Department of Pathology, and has joint appointments in the departments of Dermatology, Otolaryngology, and Craniofacial Biology. Dr. Wang’s laboratory has developed many genetically engineered mouse models of skin and head & neck cancers. These models are unique resources for evaluating the mechanisms and efficacy of the clinical trials for cancer prevention and treatments and develop novel therapeutic interventions. Research in Wang laboratory uses both mouse models and human cancer samples for cross-species comparisons. The current activities in Wang laboratory include: 1) Role of tumor microenvironment in cancer progression and metastasis; 2) Mechanisms of immune evasion of cancer and cancer immunotherapy; 3) the properties of cancer stem cells, transcriptional machinery, microRNA functions; 4) Experimental therapeutics of head and neck cancer with different genetic alterations. In addition to cancer biology, Dr. Wang’s laboratory studies molecular mechanisms of inflammatory skin diseases and normal stem cell fate determination during skin development.

Charles J Malemud is Associate Director of the Rheumatology Fellowship Training Program at University Hospitals Case Medical Center Professor of Medicine Anatomy Division of Rheumatic Diseases Case Western Reserve University School of Medicine Cleveland Ohio. He received the PhD in Experimental Pathology from the Department of Biology at George Washington University Washington DC 1969-1973. He completed his BS in Biology at Long Island University 1966. He was elected to Whomiddots Who in the World in 2007. He is serving as an editorial board member of 9 reputed journals and a peer-reviewer for numerous scientific journals. He has published a total of over 300 peer-reviewed papers abstracts and book chapters.

Andrew Klimov has completed his MD and PhD from the Immunology and Allergy Department, Siberian State Medical University, Russia. He has been working as a Associate Professor of the Immunology and Allergy Department and ENT Department, Siberian State Medical University, Russia since 2013. He has published about 30 papers in reputed journals and has been serving as the director of the Immunopathology Center LLC in Tomsk, Russia.

Eswari beeram is currently working as a Assistant Professor in Sree Vidyanikethan Degree College and she is engaged mainly in research on drug metosartan.